$KDP

Keurig Dr Pepper stock edges up on third quarter earnings beat

Keurig Dr Pepper (KDP) reported Q3 earnings of $0.66 per share, beating estimates by $0.04. Revenue was $7.34B, up 70.6% YoY. The company reaffirmed its 2026 guidance. Shares rose 1.23% in pre-market trading. CEO Tim Cofer highlighted growth in refreshment beverages and coffee segments.

Original reporting
Published Nov 3, 2026, 12:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 12:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$KDP
Bullish
high confidence
Mentioned
$KDP
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$KDPBullishHigh
01

Why it matters

The earnings beat and reaffirmed guidance support a bullish short‑term outlook, though margin pressure from inflation remains a risk.

02

Market read

The earnings surprise provides a clear trading catalyst for KDP and may influence peer beverage stocks.

03

What to watch

Potential headwinds from inflationary cost pressures and higher SG&A could temper longer‑term upside.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

KDP's Q3 results were released on Nov 3, 2026, showing modest revenue growth and a $0.04 EPS beat.

Company-level read

Ticker impact

$KDPBullishHigh confidence
Context

Keurig Dr Pepper reported Q3 earnings beat with EPS $0.66 vs $0.62 estimate and raised guidance, moving the stock up 1.2% pre‑market.

Expected impact

likely upward pressure as traders price in the earnings beat and guidance reaffirmation

Evidence & confidence

Earnings beat and solid cash flow exceed expectations; market typically rewards such results for a large‑cap consumer beverage company.

Market effects

Beverage sector may see modest lift as a major player posts strong results.

U.S. consumer discretionary stocks could benefit from the upbeat earnings.

Limited to U.S. markets; no direct global macro effect.

Counterpoint

If the market had already priced in the beat, the stock could face a short‑term pull‑back.

Key entities

  • Keurig Dr Pepper Inc.

    U.S. beverage company reporting Q3 earnings.

Related articles

$KDPMed

Keurig Dr Pepper Inc. Q3 2026 Earnings Call Summary

Keurig Dr Pepper Inc. reported Q3 2026 earnings, highlighting double-digit net sales growth in US refreshment beverages and a $1 billion milestone for Dr Pepper Zero Sugar. Energy drinks reached a 10% market share, while coffee performance was impacted by consumer shifts to lower-cost formats. The company reaffirmed low double-digit EPS growth for 2026 and confirmed plans to separate into two public companies by early 2027.

$KDPMedAI 8/10

Keurig Dr Pepper Q3 Earnings Call Highlights

Keurig Dr Pepper (KDP) reported Q3 earnings, highlighting 2.7% U.S. Coffee sales growth despite consumer value pressures. GHOST energy drink surpassed 10% market share, and Electrolit grew 40%. KDP launched the Keurig Alta system. JDE Peet's exceeded expectations, contributing $2.6B in net sales. KDP raised JDE Peet's EPS outlook but lowered legacy KDP growth expectations. The company plans to use $780M from asset sales for debt repayment and reaffirmed its 2026 sales outlook.

$KDPHighAI 9/10

Keurig Dr Pepper Reports Q3 Results and Reaffirms Guidance for 2026

Keurig Dr Pepper Inc. (KDP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Keurig Dr Pepper Reports Q3 Results and Reaffirms Guidance for 2026 Drove Healthy Q3 Net Sales Momentum, with Growth Across all Legacy KDP Segments Delivered Q3 Diluted EPS Increase of More Than 20% FRISCO, TX and BURLINGTON, MA ( November 3, 2026 ) – Keurig Dr Peppe

$KDPHighAI 8/10

Why is Keurig Dr Pepper stock sliding today?

Keurig Dr Pepper (KDP) stock fell 3.9% in pre-market trading after Q3 2026 earnings beat estimates but showed margin compression and no guidance upgrade. Adjusted EPS was $0.66 vs. $0.62 estimate, and net sales were $7.34B vs. $7.33B estimate. The company reaffirmed full-year guidance, disappointing investors.